Riyadh biotech summit targets 15,000 attendees in September

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 15,000 visitors, 100-plus speakers and delegations from over 70 countries. The event is designed to advance Saudi Arabia’s biotech strategy, which aims to generate $34.6 billion in non-oil GDP from biotechnology by 2040.

Why it matters: - The Riyadh Global Medical Biotechnology Summit is positioned as a key platform for Saudi Arabia’s National Biotechnology Strategy. - The summit is meant to connect scientific research, investment, regulation and manufacturing across the biotechnology value chain. - Saudi Arabia’s strategy targets $34.6 billion in non-oil GDP from biotechnology by 2040.

What happened: - The fourth edition of RGMBS will take place in Riyadh from 14 to 16 September 2026. - The summit will bring together scientists, investors, policymakers and health innovators. - More than 15,000 visitors are expected to attend. - More than 100 local and international speakers are scheduled. - The event expects 200 biotechnology and healthcare brands and more than 80 exhibiting entities from government and industry. - Delegations from more than 70 countries are expected. - Organizers are targeting more than 65 agreements and memoranda of understanding over the three days.

The details: - The scientific program covers six tracks: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - The agenda follows the biomedical innovation pathway from population-scale genomics and AI-enabled drug discovery to domestic biomanufacturing, regulatory science, commercialization and investment. - The summit is organized under the supervision of the Ministry of National Guard, through its Health Affairs sector. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data & AI Authority are strategic partners. - Registration is open for delegates, exhibitors and industry partners. - The full scientific program and event information are available here.

Between the lines: - The summit theme, “Building the Foundations of Biotechnology Excellence,” signals a shift from global reach to building deeper national capability. - H.E. Prof. Bandar Alknawy said the focus is on scientific infrastructure, including advanced laboratories, integrated research centers, clinical trial networks, biomanufacturing capabilities and digital platforms. - Alknawy also pointed to national talent development and leadership across academia, industry and regulation as necessary to build a resilient biotech ecosystem. - The partnership list, including Harvard University, AstraZeneca and Peking University, suggests Saudi Arabia is using international collaboration to speed translation and capability building.

What's next: - Delegates, exhibitors and industry partners can register now. - The summit will release its scientific program, speaker lineup and additional event details through rgmbs.org. - The event is expected to produce new agreements, partnerships and investment discussions during the three-day program. - The summit will continue to showcase Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and translational research capacity to international attendees.

The bottom line: - RGMBS 2026 is more than a conference. It is a marquee test of whether Saudi Arabia can turn biotech ambition into a full ecosystem for research, manufacturing and investment.